Fundz

Genialis reported raising $11.4 Million in an initial SEC Form D filing, from an offering of $13.9 Million

PRIVATEJan 31, 2023$11.4M of $13.9M raised

Amount Raised

$11.4 Million

$11.4 Million sold, per SEC Form D (first sale Jan 19, 2023)

Round Type

Venture

BostonBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as Genialis that raised within 45 days of this round, from Fundz verified event records.

  • Volastra Therapeutics raised $60M on March 3, 2023.
  • Unicycive Therapeutics raised $30M on March 3, 2023.
  • 22nd Century raised $21M (Debt Financing) on March 3, 2023.
  • Amplified Sciences raised $3M (Seed) on March 3, 2023.
  • GenoME Diagnostics raised $1.8M (Seed) on March 3, 2023.
  • PMGC Holdings Inc. raised $750K (Seed) on March 3, 2023.

Who to call at Genialis, and when

A new round usually means Genialis is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Genialis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Genialis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Genialis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Genialis

Location

68 HARRISON AVE #605

Boston, Massachusetts, United States

About

Genialis is a computational precision medicines company unravelling complex biology to find new ways to address disease. ResponderID™, Genialis’ clinical biomarker discovery platform, defines, models, and validates actionable biomarkers and optimally positions novel drugs to accelerate translational research and clinical development. Genialis is trusted by biopharma and big pharma alike, and together, we bring precision to medicine.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Genialis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsMark U., Chief Scientific Officer hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Genialis's next move

See what Strategic adds

Genialis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.